Determinants of the Vascular Response to Training in Chronic Obstructive Pulmonary Disease (COPD) Patients

Not Applicable

Terminated

• Conditions: COPD Patients; Healthy

• Registration Number: NCT03774238
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

Vascular comorbidities constitute a major burden in COPD patients. The atherosclerosis process is preceded by the onset of an endothelial dysfunction (assessed by the flow-mediated dilatation (FMD)), which is a risk factor for later ischemic vascular complications and death. In COPD, this endothelial dysfunction could be explained by intrinsic endothelial cell properties, or the effect of a pathogenic endothelial cell microenvironment (inflammation and/or oxidative stress). Exercise training constitue a powerful stimulus for the endothelial function, and could be mediated by the mobiliaztion and function of endothelial progenitors. While exercise training is an efficient intervention in COPD patients, its vascular effect appear blunted. The endothelial function response to training has appeared heterogeneous in COPD patients, and possibly linked to the endothelial cel lesion. Thus, endothelial function (assessed by the FMD) response to exercise training would be lower in COPD patients with a baseline impairment of the their FMD. In addition, of biological and functional factors could explained the magnitude of the FMD response in COPD patients.The aim of the study are thus :

To compare the FMD change in COPD patients with FMD above (FMD+) and under the median FMD (FMD-) after 4 weeks of exercise training in the whole study population.

To compare between COPD patients FMD+, COPD patients FMD- and healthy "control" subjects, the endothelial inflammation and senescence at baseline and the endothelial progenitor mobilization and function change induced by exercise (maximal exercise test and training).

To compare between COPD patients FMD+, COPD patients FMD- and healthy "control" subjects the effect of the endothelial microenvironment on the cellular pathways regulating the endothelial function in vitro at baseline and changes after exercise training.

To test in COPD patients the association between the magnitude of the FMD changes after training and biological, functional and clinical factors (inflammation oxidative stress markers, endothelial biomarkers, pulmonary impairment and phenotype, cardiovascular risks factors, vascular function, metabolic markers, physical activity level, ...)

Detailed Description

Not available

Study Timeline

• Study First Submitted: 2018-10-30
• Study First Submitted QC: 2018-12-10
• Study First Posted: 2018-12-12
• Study Start: 2019-02-20
• Primary Completion: 2024-11-20
• Study Completion: 2024-11-20
• Status Verified: 2025-02
• Last Update Submitted: 2025-02-17
• Last Update Posted: 2025-02-19

Recruitment & Eligibility

• Status: TERMINATED
• Sex: All
• Target Recruitment: 69

Inclusion Criteria

A/ COPD patients

• age between 35 and 85 years old
• spirometry showing an FEV1/VC < lower limit of normal
• with an indication for a pulmonary rehabilitation program
• written and informed consent for this study signed by the patient

B/ Healthy subjects

• age between 35 and 85 years old
• no cardiovascular or respiratory disease
• normal spirometry

Exclusion Criteria

• Unstabilized comorbidity
• Subject in a period of exclusion relative to another protocol
• Major protected by law
• Subject participating in another research protocol
• Subject not affiliated to a social security scheme
• Pregnant or lactating woman
• Patient deprived of freedom by court or administrative order

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Measure of Flow-Mediated Dilatation (FMD)	post exercise and after 4 +/- 2 weeks of training	Measure of FMD by EndoPAT2000©

Secondary Outcome Measures

Name	Time	Method
Number of colonies and function of Endothelial-Colony Formaing cells (ECFC) in vitro	post exercise and after 4 +/- 2 weeks of training
Markers of oxidative stress	after 4 +/- 2 weeks of training	Lipid peroxidation (in micromol/L)
Number endothelial progenitors	post exercise and after 4 +/- 2 weeks of training	CD34+, CD45+ and KDR + subpopulations by flow cytometry
Vascular function parameters	after 4 +/- 2 weeks of training	Pulse-wave velocity (in ms-1)
Muscle function parameters	after 4 +/- 2 weeks of training	Maximum isometric voluntary contraction (in N.m)
Exercise capacity and vascular adaptation parameters	after 4 +/- 2 weeks of training	Maximal oxygen uptake (VO2max, in mL/kg/min)
Measure of biological vascular markers	after 4 +/- 2 weeks of training	E-selectin soluble (sE-sel), endotheline 1 (ET1), facteur von Willebrand (vWF), vascular endothelial growth factor A (VEGF-A), Fms-like tyrosine kinase receptor 1 soluble (sFlt-1), Angiopoietine 1 et 2 (Ang-1 Ang-2)
Pulse-wave velocity (in ms-1)	after 4 +/- 2 weeks of training
Markers of systemic inflammation	after 4 +/- 2 weeks of training	C-Reactive protein (in ng/ml)

Trial Locations

Locations (2)

CHU Montpellier and CHU Nimes; 🇫🇷 Montpellier, France

University Hospital, Paris; 🇫🇷 Paris, France